• $1.5B
    Market Cap
  • 105.88%
    1-Year Change
  • Biotechnology
    Industry
Annual
Quarterly
12/31/2025
12/31/2024
12/31/2023
12/31/2022
Income Statement
Total Operating Revenue
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Cost of Revenue
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Gross Profit
0
N/A
0
N/A
0
N/A
0
N/A
Sales and Marketing Expense
22.0M
+43.52%
15.3M
+34.16%
11.4M
+13.22%
10.1M
+53.81%
Research and Development Expense
-38.8M
+10.71%
-35.0M
+17.42%
-29.8M
+45.58%
-20.5M
+139.49%
Depreciation and Amortization Expense
335,000
+6.35%
315,000
0.00%
315,000
+570.21%
47,000
+147.37%
Total Operating Expenses
22.0M
+43.52%
15.3M
+34.16%
11.4M
+13.22%
10.1M
+53.81%
Operating Profit
-60.7M
+20.68%
-50.3M
+22.05%
-41.2M
+34.92%
-30.6M
+102.34%
Interest Income
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Interest Expense
N/A
N/A
N/A
N/A
-63,000
N/A
0
N/A
Interest Income and Expense and Net
0
N/A
0
+100.00%
-63,000
N/A
0
N/A
Total Nonoperating Income and Expense
N/A
N/A
N/A
N/A
63,000
N/A
0
N/A
Income before Taxes
-48.3M
+23.86%
-39.0M
+9.48%
-35.6M
+58.47%
-22.5M
+144.03%
Income Taxes
0
N/A
0
N/A
0
N/A
0
N/A
Extraordinary Items
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Net Income
-48.3M
+23.86%
-39.0M
+9.48%
-35.6M
+58.47%
-22.5M
+144.03%
Net Income from Continuing Operations Applicable to Common
-48.3M
+23.86%
-39.0M
+9.48%
-35.6M
+58.47%
-22.5M
+144.03%
Basic EPS and Net Income
-0.79
+5.33%
-0.75
+10.29%
-0.68
+57.41%
-0.43
+104.74%
Diluted EPS and Net Income
-0.79
+5.33%
-0.75
+10.29%
-0.68
+57.41%
-0.43
+104.74%
Basic Weighted Average Shares
61.0M
+17.33%
52.0M
+0.01%
52.0M
+0.003%
52.0M
+19.09%
Diluted Weighted Average Shares
61.0M
+17.33%
52.0M
+0.01%
52.0M
+0.003%
52.0M
+19.09%
Balance Sheet
Cash and Cash Equivalents
246.3M
+144.32%
100.8M
+28.53%
78.4M
-52.75%
166.0M
-40.04%
Short-Term Investments
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Cash and Cash Equivalents and Short-Term Investments
246.3M
+144.32%
100.8M
+28.53%
78.4M
-52.75%
166.0M
-40.04%
Total Current Assets
286.0M
+85.43%
154.2M
-6.01%
164.1M
-2.64%
168.5M
-39.77%
Accumulated Depreciation
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Property and Plant and Equipment and Net
620,000
-17.11%
748,000
-30.03%
1.1M
+1,002.06%
97,000
+18.29%
Total Long-Term Assets
2.3M
-93.38%
34.0M
-45.27%
62.2M
-27.51%
85.8M
+104,559.76%
Total Assets
288.2M
+53.09%
188.3M
-16.80%
226.3M
-11.03%
254.4M
-9.13%
Income Taxes Payable
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Total Short-Term Debt
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Total Current Liabilities
8.4M
-6.40%
9.0M
+33.61%
6.7M
+47.40%
4.5M
+65.37%
Total Long-Term Debt
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Total Long-Term Liabilities
147,000
-60.16%
369,000
-41.52%
631,000
N/A
N/A
N/A
Total Liabilities
8.5M
-8.53%
9.3M
+27.14%
7.3M
+61.28%
4.5M
+65.37%
Retained Earnings
-154.4M
+45.07%
-106.4M
+56.68%
-67.9M
+109.09%
-32.5M
+223.73%
Total Stockholders Equity
279.7M
+56.30%
179.0M
-18.28%
219.0M
-12.35%
249.8M
-9.87%
Total Shares Outstanding
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Cash Flow
Cash from Operating Activities
-43.6M
+3.00%
-42.3M
+26.84%
-33.3M
+27.24%
-26.2M
+71.43%
Capital Expenditures
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Cash from Investing Activities
46.2M
-29.11%
65.1M
+220.40%
-54.1M
-36.12%
-84.7M
N/A
Dividends Paid
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Cash from Financing Activities
139.7M
+46,037.83%
-304,000
+49.02%
-204,000
N/A
0
-100.00%
Financials Ratio
Gross Margin
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Operating Margin
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Return on Assets
-20.26%
+7.76%
-18.80%
+26.93%
-14.81%
+76.15%
-8.41%
N/A
Return on Equity
-21.04%
+7.46%
-19.58%
+28.98%
-15.18%
+78.15%
-8.52%
N/A
Revenue Growth
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Current Ratio
34.13
+98.11%
17.23
-29.65%
24.49
-33.95%
37.07
N/A
Cash Ratio
29.39
+161.02%
11.26
-3.80%
11.70
-67.94%
36.51
N/A
Debt-to-Equity Ratio
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Debt-to-Assets Ratio
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A

Earnings & Revenue History

Debt-to-Assets

Cash Flow